Cartesian Therapeutics, Inc. (RNAC)
8.16
-0.18
(-2.16%)
USD |
NASDAQ |
May 07, 15:45
Cartesian Therapeutics Cash from Investing (Quarterly) : -0.027M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Insmed, Inc. | 389.41M |
| Regeneron Pharmaceuticals, Inc. | -428.90M |
| Precision BioSciences, Inc. | -0.114M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.14M |
| Cash from Financing (Quarterly) | 15.67M |
| Free Cash Flow | -77.37M |
| Free Cash Flow Per Share (Quarterly) | -0.8252 |
| Free Cash Flow to Equity (Quarterly) | -21.34M |
| Free Cash Flow to Firm (Quarterly) | -22.16M |
| Free Cash Flow Yield | -36.01% |